'Dong-A Socio Achieves Record Quarterly Performance... 3Q Sales 289.2 Billion KRW, Operating Profit Up 10%'

Dong-A Socio Holdings achieved its highest-ever performance since transitioning to a holding company system in 2013.

Exterior view of Dong-A Socio Holdings headquarters building
[Photo by Dong-A Socio Holdings]

Dong-A Socio Holdings announced on the 31st that its consolidated financial statement for the third quarter showed provisional operating results of KRW 289.225 billion in sales and KRW 24.772 billion in operating profit. Compared to the same period last year, sales increased by 7.3%, and operating profit also rose by 10.4%, marking the best performance since 2013. The company analyzed, "Sales were driven by the growth of Dong-A Pharmaceutical, the core business company," and "Operating profit improved evenly across business companies."

Healthcare specialist Dong-A Pharmaceutical saw sales growth driven by its business sectors including ▲Bacchus ▲Over-the-Counter (OTC) drugs ▲and daily health products. Third-quarter sales reached KRW 172.6 billion, a 13.9% increase compared to the same period last year. However, operating profit decreased by 8.1% to KRW 25.7 billion. Among the business sectors, the daily health products segment showed remarkable growth, with third-quarter sales of KRW 54.2 billion, increasing by KRW 15.6 billion (40.3%) year-on-year. The Bacchus segment increased by KRW 1.2 billion (1.7%), and the OTC segment also rose by KRW 0.5 billion (1.3%).

STGEN Bio, a biopharmaceutical specialist, recorded sales of KRW 5.8 billion, down 18.0% from the third quarter of last year. However, operating loss was reduced to KRW 2.3 billion from KRW 3.2 billion in the same period last year.

Logistics specialist Yongma Logistics posted sales of KRW 90.5 billion, matching the performance of the third quarter last year. However, operating profit surged by 140% year-on-year to KRW 4.1 billion, thanks to effects such as increased logistics unit prices and cost ratio improvements through operational stabilization. Dongchunsu, a bottled water specialist, recorded sales of KRW 9.4 billion and operating profit of KRW 0.1 billion.

Meanwhile, affiliates Dong-A ST and ST Pharm also announced their third-quarter results on the same day. Dong-A ST reported third-quarter sales of KRW 150.2 billion and operating profit of KRW 13.077 billion, with sales down 5.1% and operating profit down 7.7% compared to the same period last year. Cumulative sales up to the third quarter this year were KRW 439.5 billion, and cumulative operating profit was KRW 28.513 billion.

ST Pharm reported sales of KRW 55.947 billion and operating profit of KRW 6.669 billion, with sales down 8.0% but operating profit up 46.8% compared to the same period last year. Cumulative sales were KRW 164.365 billion, and operating profit was KRW 11.985 billion.

This content was produced with the assistance of AI translation services.